Delivery Order SPE2DB24D1021-SPE2DB25FEVXD
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$7.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,891.43, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,116.20, is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,223.32, is for the delivery of RINVOQ ER 30 MG TABLET UU 30S. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,954.88, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of March 12, 2025 and is a Firm Fixed Price Delivery Order. The contract award was not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,771.36, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. It is a Firm Fixed Price Delivery Order contract with a completion date of February 24, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,472.57 firm fixed-price delivery order is for the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,510.92, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of October 18, 2024 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,223.32, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 3, 2025. This award is not associated with a set-aside designation. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $30,519.54, is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 1, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,340.25 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...